149 related articles for article (PubMed ID: 28387905)
21. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.
Zhou J; Li W; Guo J; Li G; Chen F; Zhou J
Tumour Biol; 2016 Mar; 37(3):3561-9. PubMed ID: 26456956
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
26. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
27. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
Ding W; Tan H; Zhao C; Li X; Li Z; Jiang C; Zhang Y; Wang L
Tumour Biol; 2016 May; 37(5):6255-60. PubMed ID: 26615424
[TBL] [Abstract][Full Text] [Related]
28. Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma.
Yu G; Wang J; Xu K; Dong J
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129291
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
30. MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma.
Liu H; Li W; Chen C; Pei Y; Long X
Tumour Biol; 2015 Aug; 36(8):6313-9. PubMed ID: 25804796
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R
Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822
[TBL] [Abstract][Full Text] [Related]
32. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
Huang W; Li J; Guo X; Zhao Y; Yuan X
Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
Kim HS; Lee KS; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Yang HD; Park M; Park WS; Kang YK; Nam SW
Oncotarget; 2015 Apr; 6(10):8089-102. PubMed ID: 25797269
[TBL] [Abstract][Full Text] [Related]
34. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
35. New tumor suppressor microRNAs target glypican-3 in human liver cancer.
Cartier F; Indersie E; Lesjean S; Charpentier J; Hooks KB; Ghousein A; Desplat A; Dugot-Senant N; Trézéguet V; Sagliocco F; Hagedorn M; Grosset CF
Oncotarget; 2017 Jun; 8(25):41211-41226. PubMed ID: 28476031
[TBL] [Abstract][Full Text] [Related]
36. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
38. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
Sun X; Liu Y; Li M; Wang M; Wang Y
Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
[TBL] [Abstract][Full Text] [Related]
39. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.
Sui C; Xu F; Shen W; Geng L; Xie F; Dai B; Lu J; Zhang M; Yang J
Tumour Biol; 2015 Mar; 36(3):1511-8. PubMed ID: 25374061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]